Cough and shortness of breath were equally common among all women, symptoms such as fever were less likely with pregnancy, and pregnant women were more likely to have comorbidities and be hospitalized.
The consequences of COVID-19 in pregnant women remain incompletely understood. Investigators reviewed CDC surveillance data from January 22 to June 7, 2020, among women of reproductive age (range, 15–44). Of 91,000 women with confirmed SARS-CoV-2 infection and known pregnancy status, 8200 (9%) were pregnant.
Cough occurred in about 52% of all women and shortness of breath in 30%, but pregnant women were less likely than nonpregnant women to have fever (34% vs. 42%), muscle aches (38% vs. 47%), chills (29% vs. 36%), and diarrhea (14% vs. 23%). Diabetes mellitus, chronic lung disease, and cardiovascular disease were more frequent in pregnant than nonpregnant women. Compared with nonpregnant women, those who were pregnant were more likely to be…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)